consensus quickly developed that it would be bad to completely ban germline gene editing. The participants wanted to leave the door open. Their objective became similar to that of Asilomar: finding a path forward rather than putting on the brakes. That would become the theme of most subsequent commissions and conferences organized by scientists: it was too early to do germline editing safely, but someday it would happen, and the goal should be to provide prudent guidelines.
